These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
46 related items for PubMed ID: 7122255
21. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734 [Abstract] [Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301 [Abstract] [Full Text] [Related]
23. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. Da Costa ML, Redmond HP, Bouchier-Hayes DJ. J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264 [Abstract] [Full Text] [Related]
24. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice. Chan P. Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179 [Abstract] [Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433 [Abstract] [Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of Methyl Carbamate (CAS No. 598-55-0) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1987 Nov; 328():1-176. PubMed ID: 12732908 [Abstract] [Full Text] [Related]
27. Modulation of expression of class II MHC and CD40 molecules in murine B cells by various muramyl dipeptides. Cohen LY, Bahr GM, Darcissac EC, Parant MA. Cell Immunol; 1996 Apr 10; 169(1):75-84. PubMed ID: 8612298 [Abstract] [Full Text] [Related]
28. Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice. Ausobsky JR, Cheadle WG, Brosky BG, Polk HC. Br J Surg; 1984 Feb 10; 71(2):151-3. PubMed ID: 6362769 [Abstract] [Full Text] [Related]
30. Effects of muramyl dipeptide and core body temperature on peritoneal bacterial clearance. Stellato TA, Townsend MC, Gordon N, Danziger LH, Galloway P, Hawkins NL, Fry DE. Arch Surg; 1988 Apr 10; 123(4):465-9. PubMed ID: 3279936 [Abstract] [Full Text] [Related]
31. Cell loss from viable and necrotic tumour regions measured by 125I-UdR. Porschen R, Porschen W, Mühlensiepen H, Feinendegen LE. Cell Tissue Kinet; 1983 Nov 10; 16(6):549-56. PubMed ID: 6627346 [Abstract] [Full Text] [Related]
32. Kupffer cells and liver metastasis. Optimization and limitation of activation of tumoricidal activity. Phillips NC. Cancer Metastasis Rev; 1989 Dec 10; 8(3):231-52. PubMed ID: 2697472 [Abstract] [Full Text] [Related]
33. Vascular clearance of embolic tumor cells and colloidal carbon and the levels of serum lysozyme following muramyl dipeptide administration. Proctor JW, Waters RV, Jones GH, Gorecka-Tisera A, Yamamura Y. Oncodev Biol Med; 1982 Dec 10; 3(2-3):179-90. PubMed ID: 7122255 [Abstract] [Full Text] [Related]
34. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice. Cheadle WG, Ausobsky JR, Trachtenberg LS, Lamont P, Polk HC. Am Surg; 1986 Nov 10; 52(11):613-7. PubMed ID: 3535600 [Abstract] [Full Text] [Related]
35. Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice. Gorecka-Tisera A, Proctor JW, Yamamura Y, Harnaha J, Meinert K. J Natl Cancer Inst; 1981 Oct 10; 67(4):911-5. PubMed ID: 6944557 [Abstract] [Full Text] [Related]
36. Improvement of normothermic rat liver ischemia/reperfusion by muramyl dipeptide. Cursio R, Gugenheim J, Panaia-Ferrari P, Lasfar A, Tovey M, Chastanet S, Saint-Paul MC, Ferré C, Mouiel J. J Surg Res; 1998 Dec 10; 80(2):339-44. PubMed ID: 9878335 [Abstract] [Full Text] [Related]
37. [Role of tumor necrosis factor in lethality during endotoxic shock in mice presensitized with serum of tumor-bearing mice]. Shapoval AI. Biull Eksp Biol Med; 1993 Jan 10; 115(1):57-9. PubMed ID: 8054581 [Abstract] [Full Text] [Related]
38. Vascular clearance of embolic tumor cells and colloidal carbon and the levels of serum lysozyme following muramyl dipeptide administration. Proctor JW, Waters RV, Jones GH, Gorecka-Tisera A, Yamamura Y. Oncodev Biol Med; 1982 Jan 10; 3(2-3):179-90. PubMed ID: 7122255 [Abstract] [Full Text] [Related]
39. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice. Cheadle WG, Ausobsky JR, Trachtenberg LS, Lamont P, Polk HC. Am Surg; 1986 Nov 10; 52(11):613-7. PubMed ID: 3535600 [Abstract] [Full Text] [Related]
40. Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice. Gorecka-Tisera A, Proctor JW, Yamamura Y, Harnaha J, Meinert K. J Natl Cancer Inst; 1981 Oct 10; 67(4):911-5. PubMed ID: 6944557 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]